SCHEDULE 13G/A: BlackRock Amends Hologic Stake, Reports 8.9% Passive Ownership
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 8.9% of Hologic Inc.'s common stock as of March 31, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 16 to Schedule 13G regarding its beneficial ownership in HOLOGIC INC.
- As of March 31, 2025, BlackRock, Inc. beneficially owns 19,937,246 shares of Hologic Inc. common stock.
- This represents 8.9% of the total outstanding common stock of Hologic Inc.
- BlackRock holds sole voting power over 17,891,864 shares and sole dispositive power over all 19,937,246 shares.
- The filing confirms that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Hologic Inc.
Sentiment
Score: 7
Explanation: The document is a routine passive ownership disclosure. The continued significant stake by a major institutional investor like BlackRock is generally a positive signal of confidence, though it provides no new operational or financial insights into Hologic Inc. itself.
Positives
- BlackRock's continued significant passive stake (8.9%) in Hologic Inc. indicates a long-term investment perspective from a major institutional investor.
- The filing confirms BlackRock's intent as a passive investor, suggesting stability in its holding without seeking to influence company control.
Future Outlook
The document, a Schedule 13G filing, does not provide forward-looking statements or guidance regarding Hologic Inc.'s future performance or BlackRock's investment strategy beyond its passive intent.
Management Comments
- "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."
Industry Context
This filing is a routine disclosure by a large institutional asset manager, BlackRock, regarding its passive stake in Hologic Inc., a medical technology company. It reflects BlackRock's ongoing portfolio management and does not indicate any specific industry trends or competitive shifts, but rather its continued confidence in Hologic as an investment.
Comparison to Industry Standards
- As a Schedule 13G filing, this document primarily details an institutional investor's ownership stake and does not provide performance metrics for Hologic Inc. that would allow for direct comparison to industry standards or specific comparable companies/projects. The 8.9% stake is a significant passive holding for a large asset manager like BlackRock in a company of Hologic's size.
Stakeholder Impact
- Shareholders: Provides transparency on a major institutional investor's significant passive stake, which can be viewed as a vote of confidence.
- Management: Confirms that a large shareholder is not seeking to influence control, allowing management to focus on operations without activist pressure from this specific investor.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney date, which was revoked by the new one. |
| 2025-01-21 | Effective date of the new Power of Attorney for BlackRock, Inc. signatories. |
| 2025-03-31 | Date of event which requires filing of this statement, representing the reporting period end date for beneficial ownership. |
| 2025-04-17 | Signature date of the Schedule 13G/A filing by BlackRock, Inc. |
Keywords
Hologic Inc, BlackRock Inc, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, Passive Investment, Medical Technology, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.